Sign in

Prof John Gordon

@profcelentyx.bsky.social
190 followers 105 following 95 posts

B Cell Enthusiast; Immunology Prof (Emeritus, but Still Breathing); Big on Immunotherapy; Love Herefordshire; & Curries 😃 Any views and comments are strictly personal

PostsRepliesMedia
Prof John Gordon @profcelentyx.bsky.social · 31/10/2025
Wild!!
000
Prof John Gordon @profcelentyx.bsky.social · 31/10/2025
Thrilled and honoured to be invited onto the Scientific Advisory Panel of the Centre for Human-Specific Research 😊 humanspecificresearch.org
010
Prof John Gordon @profcelentyx.bsky.social · 24/10/2025
Incredible #infection #immunity #cancer #Bcells #Tcells Resource 👏 Top of the Human League 🙋‍♂️🙋‍♀️
021
Prof John Gordon @profcelentyx.bsky.social · 14/08/2025
#cancersky #immunosky #antibodysky Major #CD40 #TherapeuticAntibody Success now breaking @cp-cancercell.bsky.social First-in-Human study of Fc-optimised CD40 agonistic Antibody elicits #TertiaryLymphoidStructures & systemic anti-Tumor #Immunity in Metastatic #Cancer Fantastic work 👏
cell.com
Fc-optimized CD40 agonistic antibody elicits tertiary lymphoid structure formation and systemic antitumor immunity in metastatic cancer
Osorio et al. report a first-in-human study of intratumoral 2141-V11, an Fc-engineered CD40 agonistic antibody, showing it is safe and induces systemic and durable antitumor immunity in patients with ...
010
Prof John Gordon @profcelentyx.bsky.social · 30/07/2025
Dr Neil Bodie (June 13, 1955 - July 19, 2025) It is with a heavy heart that I report the sad news that my "LinkedIn Friend" & Colleague Dr Neil Martin Bodie, passed away on July 19th. For more about Neil please see: www.linkedin.com/feed/update/... R.I.P. Dear Friend Thoughts are with his family
110
Prof John Gordon @profcelentyx.bsky.social · 26/07/2025
Major study, great work 👍
000
Prof John Gordon @profcelentyx.bsky.social · 11/06/2025
#immunosky #cancersky #climatechangesky #PsychoNeuroImmunology #ClimateChange / #SocialDivision: A Perfect Storm for Chronic #Inflammation to Seedbed #Cancer? Intriguing, OPEN ACCESS Opinion Piece now breaking at @wiley.com #Immunology
onlinelibrary.wiley.com
Inflammation Perfect Storm: Cancer, Climate and Polarisation
Interplay between major global challenges and human health. Climate change and sociopolitical polarisation act as overarching amplifiers, driving specific environmental and psychosocial/policy-relate...
031
Prof John Gordon @profcelentyx.bsky.social · 07/06/2025
A Perfect Selection 😉
010
Prof John Gordon @profcelentyx.bsky.social · 07/06/2025
Fantastic advance 👏
020
Prof John Gordon @profcelentyx.bsky.social · 30/05/2025
Clucking Awesome 🐓
010
Prof John Gordon @profcelentyx.bsky.social · 30/05/2025
A fantastic #MS resource from @britsocimm.bsky.social 👍
000
Prof John Gordon @profcelentyx.bsky.social · 22/05/2025
#Immunosky #Cancersky Antidepressants: A “Dead SERT” for #Immunotherapy! Open Access @cellpress.bsky.social @gilliangrafton.bsky.social 😎
cell.com
Serotonin transporter inhibits antitumor immunity through regulating the intratumoral serotonin axis
Serotonin transporter (SERT) inhibits CD8 T cell antitumor immunity by depleting intratumoral serotonin. SERT-blocking selective serotonin reuptake inhibitor (SSRI) antidepressants enhance CD8 T cell ...
131
Prof John Gordon @profcelentyx.bsky.social · 02/05/2025
#CancerSky #MedSky "When #Cancer #Therapy faces STIFF competition" OPEN ACCESS Review @cp-trendscancer.bsky.social
cell.com
Tissue mechanics in tumor heterogeneity and aggression
Tumorigenesis ensues within a heterogeneous tissue microenvironment that promotes malignant transformation, metastasis and treatment resistance. A major feature of the tumor microenvironment is the he...
022
Prof John Gordon @profcelentyx.bsky.social · 01/05/2025
#ImmunoSky #MedSky #CancerSky "Strengthening the #GLUT5" for #ACT vs Solid #Tumours" Breaking OPEN ACCESS Study @britsocimm.bsky.social journal @imtadvances.bsky.social 👏
academic.oup.com
GLUT5 armouring enhances adoptive T cell therapy anti-tumour activity under glucose-limiting conditions
AbstractBackground. Cancer immunotherapy with engineered T cells has become a standard treatment for certain haematological cancers. However, clinical tria
042
Prof John Gordon @profcelentyx.bsky.social · 14/04/2025
#ImmunoSky #InflammationSky #DietSky #ILC3s #Immunity #Inflammation #Mucosa #Metabolism #Nutrition #Diet #IL22 "Trust Your #Gut" & Stay Off those Big Macs 🍔 @wehi-research.bsky.social researchers Cyril Seillet & Friends "Chew the #Fat" in Breaking OPEN ACCESS Study @cp-immunity.bsky.social
cell.com
Acute exposure to high-fat diet impairs ILC3 functions and gut homeostasis
Xiong et al. report that short-term, high-fat diet exposure rapidly alters the gut microbial and immune environment, disrupting tissue homeostasis. IL-22 production by group 3 innate lymphoid cells (I...
092
Prof John Gordon @profcelentyx.bsky.social · 13/04/2025
#ImmunoSky #MedSky #CancerSky #PharmaSky #DrugSky **BREAKING: Massive layoffs hit the rodent workforce!** In a historic shift, the FDA is exploring a future without animal studies for drug approvals. BRILLIANT Joseph Arboleda Velasquez @harvard.edu 🤩👍👏 www.linkedin.com/posts/joseph...
120
Prof John Gordon @profcelentyx.bsky.social · 11/04/2025
#CancerSky #ImmunoSky #MedSky #Cancer #Aging #Metabolism #TIME to Watch you Eat' #Age- & #Diet- instructed Metabolic Rewiring of the #TumorImmuneMicroEnvironment #TIME-ly review from @unil.bsky.social authors now breaking at @jem.org rupress.org/jem/article/...
020
Prof John Gordon @profcelentyx.bsky.social · 10/04/2025
#ImmunoSky #MedSky #drugrepurposing #Inflammation: "Time to halt the #Dopamine rush" An anti- #Psychotic Drug stimulates #Macrophages to clear #Pathogenic Cells by inducing #Arginase-1 & continual #Efferocytosis Now @science.org signaling
science.org
The antipsychotic drug thiothixene stimulates macrophages to clear pathogenic cells by inducing arginase 1 and continual efferocytosis
Macrophages perform repeated rounds of phagocytosis in response to an FDA-approved dopamine blocker.
031
Prof John Gordon @profcelentyx.bsky.social · 09/04/2025
#ImmunoSky #MedSky #EarlyCareerResearchers #Careers @ki.se
linkedin.com
From Serendipity to Success - Researcher blogs % | John Gordon
#Serendipity | Delighted to share this lovely post from the hugely talented Austeja Baleviciute of the Karolinska Institutet 😊 Hopefully will offer some useful tips to early career researchers as they...
110
Prof John Gordon @profcelentyx.bsky.social · 09/04/2025
#ImmunoSky #Immunotherapy #ImmuneRelatedAdverseEvents #Biomarkers #ICOS+ CD4 #Tcells define #Susceptibility to anti-PD1-induced #Lung #Pathology in the #Aged #Bcells #Antibodies #TertiaryLymphoidStructures Breaking Open Access Study @jci-insight.bsky.social insight.jci.org/articles/vie...
030
Prof John Gordon @profcelentyx.bsky.social · 04/04/2025
Maximizing activity & selectivity of #TherapeuticAntibodies mediated effector functions using Antibody mixtures Breaking Open Access Study* @tandfresearch.bsky.social #mAbs *https://www.tandfonline.com/doi/full/10.1080/19420862.2025.2480666?src=exp-la#abstract
010
Prof John Gordon @profcelentyx.bsky.social · 03/04/2025
#Bcells & #VaccinesSaveLives Towards a pan- #Flu #Vaccine Identification of a seasonal influenza vaccine–induced broadly protective neuraminidase antibody Breaking Open Access Study* @jem.org *https://rupress.org/jem/article/222/6/e20241930/277361/Identification-of-a-seasonal-influenza-vaccine
linkedin.com
#flu #vaccine #protective #antibody #jem #bcells #vaccinessavelives | John Gordon
Towards a pan-#Flu #Vaccine | Identification of a Seasonal Influenza Vaccine-induced Broadly #Protective Neuraminidase #Antibody | Breaking Open Access Study at Rockefeller University Press #JEM | #Bc...
010
Prof John Gordon @profcelentyx.bsky.social · 03/04/2025
#Celentyx
linkedin.com
#biohubis10 | University of Birmingham Enterprise
BioHub-based Celentyx Ltd is a highly specialised contract research organisation (CRO) that delivers services across a broad range of therapeutic areas…
000
Prof John Gordon @profcelentyx.bsky.social · 01/04/2025
#Bcells #Antibodies #PlasmaCells It’s #APRIL 😎 Don’t be a Fool - Read this 👍
frontiersin.org
Frontiers | Decoding plasma cell maturation dynamics with BCMA
010
Prof John Gordon @profcelentyx.bsky.social · 31/03/2025
Targeting the #FcRn in #AutoimmuneDiseases: Pipeline & Progress Torleif Tollefsrud Gjølberg & Colleagues Dig Deep into the Biology of the Neonatal Fc Receptor & its Antagonism in Superlative Breaking Open Access Review
link.springer.com
Targeting the Neonatal Fc Receptor in Autoimmune Diseases: Pipeline and Progress - BioDrugs
Autoimmune diseases are highly prevalent and affect people at all ages, women more often than men. The most prominent immunological manifestation is the production of antibodies directed against self-...
000
Prof John Gordon @profcelentyx.bsky.social · 29/03/2025
#MyeloidCell path to #Malignancy: insights into #Liver #Cancer SUPERLATIVE OPEN ACCESS REVIEW from Christel Ramirez & @leilaakkari.bsky.social at @cp-trendscancer.bsky.social 👏 www.cell.com/action/showP...
021
Prof John Gordon @profcelentyx.bsky.social · 27/03/2025
Time to Zap moDc to reverse #Radiotherapy resistance ☢️ Breaking Open Access Study @jem.org 👍
rupress.org
CD301b+ monocyte-derived dendritic cells mediate resistance to radiotherapy | Journal of Experimental Medicine | Rockefeller University Press
Radiotherapy not only kills tumors but also shapes immunity. This study reveals that in radioresistant tumors, clinically relevant radiotherapy induces GM-
010
Prof John Gordon @profcelentyx.bsky.social · 26/03/2025
Breaking Study @nature.com #VaccineDesign with a #STING in its tail 🦂 Perfect for @britsocimm.bsky.social #Vaccine Awareness Day 👍
nature.com
Crucial meeting: molecule helps vaccine to interact with killer T cells
Vaccines containing peptides called antigens are bad at stimulating key immune cells called killer T cells. A molecule now enables antigens to encounter these T cells.
021
Prof John Gordon @profcelentyx.bsky.social · 26/03/2025
👏 #Antibodies 👏 #Immunity 👏 #Influenza 👏 #Vaccines 👏 Thank Goodness for #Bcells 😊 On @britsocimm.bsky.social #Vaccine Engagment Day check out this exciting new study from @guthmillerjenna.bsky.social et al at @cp-immunity.bsky.social: www.cell.com/immunity/abs...
linkedin.com
#bcells #immunity #vaccinedesign | John Gordon
#Bcells | "STALK-ing 'Flu" at #Immunity Cell Press: "Playing the Long Game" | Major #VaccineDesign Study by Jenna Guthmiller et al Now Breaking Online | In…
142
Prof John Gordon @profcelentyx.bsky.social · 24/03/2025
#Bcells #Antibodies #Vaccines #STALKing #Flu: "Playing the Long Game" Major #VaccineDesign Study by @guthmillerjenna.bsky.social & Friends now breaking at @cellpress.bsky.social #Immunity
cell.com
Long-lasting B cell convergence to distinct broadly reactive epitopes following vaccination with chimeric influenza virus hemagglutinins
Next-generation influenza vaccines aim to overcome the limitations of current seasonal vaccines and generate durable and broadly protective immunity against influenza by targeting conserved epitopes. ...
000
Prof John Gordon @profcelentyx.bsky.social · 24/03/2025
TODAY 👍 @britsocimm.bsky.social Oxford #Immunology Symposium Celentyx will be showcasing exciting new elements of their #Immunooncology #Immunotherapy #Discovery Platforms
linkedin.com
Come and see us at poster #5 Celentyx Ltd at the British Society for… | Jonathan Silk
Come and see us at poster #5 Celentyx Ltd at the British Society for Immunology day in Oxford
010
Prof John Gordon @profcelentyx.bsky.social · 24/03/2025
#Immunotherapy #Resistance #RAMP-ing up #Bcells makes #ICB therapy of #ESCC Nervous Open Access Study at @discovimmunol.bsky.social @britsocimm.bsky.social
academic.oup.com
Intra-tumoural RAMP1+ B cells promote resistance to neoadjuvant anti-PD-1-based therapy in esophageal squamous cell carcinoma
AbstractIntroduction. The application of neoadjuvant immunotherapy in esophageal squamous cell carcinoma (ESCC) reactivates anti-tumour immune responses an
052
Prof John Gordon @profcelentyx.bsky.social · 17/03/2025
#Vaccines Novel strategy to boost immune responses in immunisation protocols @unisouthampton.bsky.social Immunologists / Cancer Biologists clearly on fire right now 🔥 Breaking publication at another @britsocimm.bsky.social journal @ceijournal.bsky.social this time 👏
academic.oup.com
FcγRIIB (CD32B) antibodies enhance immune responses through activating FcγRs
Abstract. Fc receptors (FcR) play a key role in coordinating responses from both the innate and adaptive immune system. The inhibitory Fc gamma receptor (F
051
Prof John Gordon @profcelentyx.bsky.social · 17/03/2025
#Cancer #Immunotherapy #TAM -pering with the #TumorMicroEnvironment Therapeutic targeting of tumour-associated macrophage receptors Terrific Open Access Review from @unisouthampton.bsky.social researchers Online @imtadvances.bsky.social @britsocimm.bsky.social academic.oup.com/immunotherap...
042
Prof John Gordon @profcelentyx.bsky.social · 13/03/2025
Just back from wonderful First Night gig from the brilliant @dannythechamp.bsky.social supported by the super talented @anniedressner.bsky.social 🎵🎹🎤🎸🥁🎶🏴󠁧󠁢󠁷󠁬󠁳󠁿 Catch them if you can 🤩👍
041
Prof John Gordon @profcelentyx.bsky.social · 10/03/2025
Not to be sniffed at…
011
Prof John Gordon @profcelentyx.bsky.social · 10/03/2025
Terrific #ImmunoAgeing Review @jimmunol.bsky.social from @linterman.bsky.social & friends @babrahaminst.bsky.social "Thanks for the #Memory" #Bcells #GerminalCenter #Immunity #Infection #Vaccination #Antibodies
academic.oup.com
The cellular factors that impair the germinal center in advanced age
Abstract. Long-lasting immunological memory is a core feature of the adaptive immune system that allows an organism to have a potent recall response to for
040
Prof John Gordon @profcelentyx.bsky.social · 10/03/2025
#Immunotherapy Advances #CTLA4: two pathways to anti- #tumour #immunity? Breaking Open Access Review @imtadvances.bsky.social @britsocimm.bsky.social
linkedin.com
#cancer #tumour #immunity #ctla4 #tregs #immunecheckpointblockade… | John Gordon
#Cancer | #Tumour #Immunity | #CTLA4: "A Tale of Two Pathways" | Breaking OPEN ACCESS Review Online from Frank Ward & Co. | BOTH #Tregs-Depletion AND…
021
Prof John Gordon @profcelentyx.bsky.social · 09/03/2025
#Immunologists need to get out of the lab more 😉 #HygieneHypothesis #RunWild #RunFree #BGood
032
Prof John Gordon @profcelentyx.bsky.social · 07/03/2025
#XX marks the spot!! Fab #Bcells #SexualDimorphism #Hormones #Inflammation #AutoimmuneDiseases Study AND it's OPEN ACCESS at @jem.org 👏
000
Prof John Gordon @profcelentyx.bsky.social · 06/03/2025
#Paediatrics | #Cancer | #ImmuneSystem | #Immunotherapy | Yet Another Phenomenal Resource from @petterbrodin.bsky.social & Friends | Breaking OPEN ACCESS Study Online at @cellpress.bsky.social | #immunogenicity | #Tcells | #inflammation |
cell.com
Systems-level immunomonitoring in children with solid tumors to enable precision medicine
In a population-based cohort of 191 children with diverse solid tumors, systems-level analyses unravel immune variation with age and tumor type and provide a reference for future precision immunothera...
031
Prof John Gordon @profcelentyx.bsky.social · 06/03/2025
Fantastic breaking review @bloodjournal.bsky.social #immunotherapy #monocytes #macrophages
sciencedirect.com
The contribution of the monocyte-macrophage lineage to immunotherapy outcomes
Macrophages execute core functions in maintaining tissue homeostasis, in which their extensive plasticity permits a spectrum of functions from tissue …
000
Prof John Gordon @profcelentyx.bsky.social · 23/02/2025
Fantastic #Tregs work @jonasns.bsky.social et al 👏 Massive implications for #immunotherapy advances Finding @bsky.app really useful for picking up the occassional milestone study that may have otherwise slipped-the-net!
linkedin.com
John Gordon on LinkedIn: #tregs #singlecell #suppression #regulatorytcells #immunotherapy
#Tregs: Head-to-Head; One-by-One | #SingleCell #Suppression Profiling of Human #regulatoryTcells | Jonas N. Søndergaard et al drill down to individual Effector…
000
Prof John Gordon @profcelentyx.bsky.social · 20/02/2025
Major New #Bcells #Immunotherapy Target #Biomarker in #Cancer at @science.org #TM
science.org
Dysfunctional CD11c−CD21− extrafollicular memory B cells are enriched in the periphery and tumors of patients with cancer
Tumor-associated extrafollicular B cells are phenotypically, locationally, and functionally distinct from germinal center–dependent memory B cells.
010
Prof John Gordon @profcelentyx.bsky.social · 19/02/2025
#TumorMicroEnvironment | #LymphaticVessels: "The Shape of Things to Come" | Lymphatic #Transport in anti- #Tumor #Immunity & #Metastasis | Breaking Review at @rupress.org @jem.org | rupress.org/jem/article/...
020
Prof John Gordon @profcelentyx.bsky.social · 19/02/2025
#NKcells #Cancer #Immunotherapy Fingering the Mass Murderers & Serial Killers Fantastic work from @worboyslab.bsky.social @dandavis101.bsky.social & friends at @frontiersin.bsky.social #Immunology
linkedin.com
John Gordon on LinkedIn: #cancer #immunotherapy #nkcells #cd8α #cd70 #human #cytotoxicity…
#Cancer | #Immunotherapy | #NKcells | #CD8α and #CD70 mark #Human NK populations differing in #Cytotoxicity | Daniel Davis & Co.'s "I.D. Parade" finger Mass…
000
Prof John Gordon @profcelentyx.bsky.social · 18/02/2025
#ImmuneCheckPointBlockade in #CRC: The More the Merrier 👍 New #Colorectal #Cancer #Immunotherapy #Resistance insights at @biorxiv-immuno.bsky.social online now From @icahn.bsky.social @mountsinainyc.bsky.social researchers 👏
linkedin.com
John Gordon on LinkedIn: #immunotherapy #macrophage #tcells #immunecheckpointblockade #colorectal…
#Immunotherapy | Coordinated #Macrophage ↔ #Tcells interactions mediate response to #ImmuneCheckpointBlockade in #Colorectal #Cancer | Multiple Immune…
010
Prof John Gordon @profcelentyx.bsky.social · 12/02/2025
#Immunity | #Bcells | Gut #IgA functionally interacts with systemic #IgG to enhance #Vaccine responses | Open Access Study breaking online at @science.org #Immunology |
science.org
Gut IgA functionally interacts with systemic IgG to enhance antipneumococcal vaccine responses
Gut IgA enhances systemic IgG responses to pneumococcal vaccines through a complex mechanism involving peripheral B and T cells.
000
Prof John Gordon @profcelentyx.bsky.social · 12/02/2025
#Nipocalimab, an immunoselective #FcRn blocker that lowers #IgG and has unique molecular properties #autoimmunity #alloimmunity #therapeuticantibodies Breaking study from @johnsonandjohnson.bsky.social www.tandfonline.com/doi/full/10....
000
Prof John Gordon @profcelentyx.bsky.social · 11/02/2025
On International Day of Women and Girls in Science, remembering the late, great Eva Klein 1925 - 2025 Mother of #NKcells, #BurkittLymphoma lines, & much much more Honoured to have known and shared highly memorable times with Eva @ki.se 🇸🇪
000